UP FRONT
The Society Pages
The Votes Are In... ASH Announces
Executive Committee Election Results
On October 14, the American Society of Hematology announced the election of four new members to its Executive Committee for terms beginning after the 2014 ASH
Annual Meeting, December 6-9 in San Francisco.
• Kenneth C. Anderson, MD, will serve a one-year term
as vice president, followed by successive terms as
president-elect and president.
• Susan B. Shurin, MD, will serve a four-year term as
treasurer.
“The field of hematology is changing rapidly around
us – from the way we educate trainees to the way we
deliver care at the patient bedside. These changes
present opportunities and challenges that must be
met by visionary leadership,” said ASH President
Linda J. Burns, MD. “Drs. Anderson, Shurin, Dinauer,
and Gernsheimer bring vast knowledge and diverse
experience to address these opportunities and challenges, and we look forward to working with them to
help further the Society’s mission to conquer blood
diseases worldwide.”
Learn more about the newly elected members below.
• Mary C. Dinauer, MD, PhD, and Terry B. Gernsheimer,
MD, will both serve four-year terms as councillors.
Congratulations to the
Newly Elected Institute
of Medicine Members
On October 20, the Institute of Medicine
(IOM) announced the names of 70 new
members and 10 foreign associates during its 44th annual meeting – many of
whom are leaders in the field of hematology/oncology. These individuals were
selected by current active members in
recognition of their outstanding professional achievement, commitment to
service, and dedication to advancing
health and medicine.
The Society would like to recognize
two newly elected IOM members:
• Margaret A. Shipp, MD, chief, division
of hematologic neoplasia, Dana-Farber
Cancer Institute, Boston, MA
• Todd R. Golub, MD, investigator,
Howard Hughes Medical Institute;
chief scientific officer, Broad Institute
of Harvard and MIT; and Charles A.
Dana Investigator, Dana-Farber Cancer
Institute, Cambridge, MA
For the full list of newly elected IOM
members, visit www.iom.edu.
Kenneth C. Anderson, MD
Dr. Anderson is Director of the
Lebow Institute for Myeloma
Therapeutics and the Jerome
Lipper Myeloma Center at
Dana-Farber Cancer Institute in
Boston. He also serves as Kraft
Family Professor of Medicine and
Vice Chair of the Joint Program in
Transfusion Medicine at Harvard
Medical School. Dr. Anderson’s
major fields of interest include
the biology and treatment of
plasma cell disorders and transfusion. Outside of the laboratory,
Dr. Anderson is interested in
identifying new opportunities for
mentorship and role models to
attract the next generation into
hematology, as well as strengthening international leadership to
improve the care of patients with
blood disorders across the world.
During his more than 15 years of
involvement in ASH, Dr. Anderson
has served in a variety of Society
volunteer roles. Currently, he
serves as Executive Editor of
Hematology (the ASH Education
Program), and he served a fouryear term as an ASH councillor
from 2010-2013.
10
ASH Clinical News
Susan B. Shurin, MD
Dr. Shurin is Senior Adviser to
the Center for Global Health of
the National Cancer Institute at
the National Institutes of Health
(NIH) in Bethesda, Maryland,
working from San Diego. Her
most recent NIH roles have
included Deputy and Acting Director of the National Heart, Lung,
and Blood Institute. Her fields of
interest include non-malignant
hematologic diseases, pediatric
oncology, non-communicable
diseases, and the biology and
epidem iology of cardiovascular,
pulmonary, and blood diseases.
Dr. Shurin has previously served
as a member of the ASH Committee on Government Relations
and as faculty for the ASH Clinical
Research Training Institute.
Mary C. Dinauer, MD, PhD
Dr. Dinauer is the Fred M. Saigh
Distinguished Chair in Pediatric
Research and Professor of
Pediatrics and of Pathology and
Immunology at Washington
University School of Medicine in
St. Louis. She is also the Scientific
Director at the Children’s Discovery Institute of Washington
University and St. Louis Children’s
Hospital. Dr. Dinauer’s fields
of interest include molecular
mechanisms of innate immunity,
inflammatory responses, and
the development and function
of white blood cells. Dr. Dinauer
currently serves as an Associate
Editor of Blood and served as a
Scientific Program Co-Chair of the
2011 ASH Annual Meeting.
Terry B. Gernsheimer, MD
Dr. Gernsheimer is Medical Director of the Platelet Immunology
Laboratory at Puget Sound Blood
Center, Medical Director of Transfusion at the Seattle Cancer Care
Alliance, and Assistant Medical
Director of Clinical Transfusion
Service at the University of Washington Medical Center. She also
serves as Professor of Medicine in
the Division of Hematology and
Adjunct Professor of Laboratory
Medicine at the University of
Washington. Dr. Gernsheimer’s
major research interests include
platelet immunology and immune platelet disorders, platelet
transfusion and hemostasis in
hematologic malignancies, and
hemostasis and transfusion
management of the perioperative
patient. She currently serves on
the ASH Committee on Practice.
Former ASH President
David Nathan Awarded
Lifetime Impact Award
David G. Nathan, MD, president emeritus of Dana-Farber Cancer Institute and
physician-in-chief emeritus of Boston
Children’s Hospital, was honored as the
inaugural recipient of the Boston Children’s Hospital Lifetime Impact Award
at the hospital’s recent Annual Global
Pediatric Innovation Summit, Taking on
Tomorrow. In addition to his leadership
at both Harvard teaching hospitals, Dr.
Nathan, a former president of the American Society of Hematology, was a pioneer in pediatric hematology/oncology
and was – and continues to be – a mentor to generations of leading clinicians
and physician-scientist researchers.
The Boston Children’s award recognizes
a clinician and/or researcher who has
devoted his/her entire career to accelerating innovation in pediatric medicine,
as well as to provide national and international recognition to an individual who
has made extraordinary and sustained
leadership contributions throughout
their career to improve health care in the
field of pediatrics. ●
December 2014